| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.67 | 0.02 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.06 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |